115 top medical experts on Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency across 13 countries and 5 U.S. states, including 11 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency: A very rare neonatal epileptic encephalopathy disorder characterized clinically by onset of severe seizures within hours of birth that are not responsive to anticonvulsants, but are responsive to treatment with pyridoxal phosphate.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Synonyms: PNPO-Related Neonatal Epileptic Encephalopathy,  PNPO Deficiency,  PNPO-Related Neonatal Epileptic Encephalopathy,  Pyridoxal 5'-Phosphate-Dependent Epilepsy,  Pyridoxine-5'-Phosphate Oxidase Deficiency,  PLP-Sensitive Pyridoxine-Resistant Seizures


  

        

                    


    Computing Expert Listing ...